Trump signs executive order to accelerate psychedelic research and FDA approval for veterans

President Donald Trump signed an executive order on Saturday to accelerate research and FDA approval of psychedelic-based therapies, targeting treatments for post-traumatic stress disorder (PTSD), depression, addiction, and other mental health conditions, with a particular focus on helping veterans. The move aims to remove , expedite reviews for psychedelics designated as breakthrough therapies, and facilitate faster rescheduling of approved drugs, as Trump announced in the Oval Office.